• Users Online: 212
  • Print this page
  • Email this page


 
 Table of Contents  
UPDATE ON RETINOPATHY OF PREMATURITY
Year : 2022  |  Volume : 36  |  Issue : 3  |  Page : 251-259

Anesthesia in retinopathy of prematurity


Department of Ophthalmology, College of Medicine, King Saud University, Riyadh, Saudi Arabia

Date of Submission20-Oct-2021
Date of Decision31-Dec-2021
Date of Acceptance01-Jan-2022
Date of Web Publication14-Oct-2022

Correspondence Address:
Prof. Marwan A Abouammoh
Department of Ophthalmology, College of Medicine, King Saud University, P O Box 245, Riyadh 11411
Saudi Arabia
Login to access the Email id

Source of Support: None, Conflict of Interest: None


DOI: 10.4103/sjopt.sjopt_229_21

Rights and Permissions
  Abstract 


Retinopathy of prematurity (ROP) remains among the leading causes of childhood blindness. It affects mainly premature infants who tend to be systematically and clinically unstable and are more prone to complications and anesthesia related adverse effects when undergoing examination or treatment. A better comprehension of different analgesic and anesthetic methods used during screening and treatment may help in choosing a suitable option for ROP screening and treatment. An electronic search was done using MEDLINE, PubMed, and Embase databases. Search terms used included ROP, ROP, ROP screening, ROP treatment, analgesia, and anesthesia. All randomized clinical trials, large case series, and surveys were included in the review. Topical proparacaine is the most commonly used anesthesia during ROP screening and may significantly ease pain during ROP screening. Different comfort measures during screening may help infants recover faster but do not abolish pain. Topical tetracaine seems an effective pain-relieving option during intravitreal injections for ROP treatment. Photocoagulation of the peripheral retina under general anesthesia is considered the most common practice in the treatment of ROP. Further work is necessary to better understand the options of anesthesia methods offered for the treatment of ROP patients. This is a comprehensive review highlighting the available anesthetic methods for ROP patients to aid ophthalmologists in determining the most common and current anesthetic and analgesic practices.

Keywords: Anesthesia, retinopathy of prematurity, retinopathy of prematurity


How to cite this article:
Alselaimy R, Al Tawil L, Abouammoh MA. Anesthesia in retinopathy of prematurity. Saudi J Ophthalmol 2022;36:251-9

How to cite this URL:
Alselaimy R, Al Tawil L, Abouammoh MA. Anesthesia in retinopathy of prematurity. Saudi J Ophthalmol [serial online] 2022 [cited 2023 Jan 30];36:251-9. Available from: https://www.saudijophthalmol.org/text.asp?2022/36/3/251/358595




  Introduction Top


Retinopathy of prematurity (ROP) is a leading cause of blindness in premature infants around the globe.[1] Over 20,000 infants are blinded yearly from ROP, and another 12,300 suffer from visual impairment.[2] Important risk factors associated with the development of ROP are infants with unstable clinical courses with low birth weight and gestational age, low Apgar score, and prolonged use of oxygen therapy.[3],[4]

Untreated ROP can cause severe visual handicap. Thus, screening is very essential to identify the disease and reduce its burden by early intervention.[1] One important point to take into consideration when screening ROP patients, other than the age and weight, is the infant's clinical status.[5] Premature infants are unstable systemically compared to full-term infants of the same postnatal age, and are more prone to systemic complications such as apnea and bradycardia.[6],[7] Respiratory distress syndrome, neonatal sepsis, anemia, thrombocytopenia, and multiple blood transfusions have also been significantly associated with preterm infants with ROP.[5] Thus, care must be taken during screening for ROP as pain and discomfort may result in low oxygen tension, bradycardia, and even apnea.

A wide variety of anesthetic techniques used for the treatment of ROP have been established. General anesthesia (GA) was found to be the most common type, especially during laser photocoagulation, followed by topical anesthesia.[8] Intravenous, oral, and rectal sedation using different anesthetic agents have also been reported.[9]

The aim of this study is to provide a focused comprehensive literature review aiming to highlight all available methods of anesthesia and analgesia used during ROP screening and treatment.


  Literature Search Top


We searched for the following keywords in PubMed, MEDLINE, and Embase databases in various combinations: ROP, ROP, ROP screening, ROP treatment, randomized controlled trials (RCTs), cohort, case series, analgesia, and anesthesia. Further studies were identified through citations, which were retrieved and examined for relevance, and included in this review. The medical subject heading search used terms relevant to the target disease, treatments, and study methods. Titles and abstracts of retrieved articles were read to identify possible RCTs, cohort, or case series. When in doubt whether to include a certain study, the full article in print was read before a decision was made. Further studies were identified through citations, which were retrieved and examined for relevance, and included in this review. Non-English papers, case reports, and animal-based studies were excluded.


  Retinopathy of Prematurity Screening Top


Pharmacological measures

Topical anesthesia

Screening and examining infants with ROP causes distress, discomfort, and pain.[10] Systemic effects such as apnea and bradycardia might be noted in those infants while they are being screened.[10] Minimizing such events is a priority for infants, examiners (ophthalmologists), and parents to achieve successful examinations. Deciding which comfort method to apply is still controversial and literature does not provide consensus as to which method is the most effective in reducing pain.[11]

An online survey was distributed to the American Association for Pediatric Ophthalmology and Strabismus members to identify the patterns of topical anesthetics used during ROP screening. Out of the 225 members, 82% utilized topical anesthetics and proparacaine was the most used agent of choice, representing 63%.[12]

In 1993, Saunders et al. performed a trial on premature infants undergoing ROP examination to assess the efficacy of topical anesthetic eye drops in decreasing infant stress. Infants were randomized to receive proparacaine 0.5% or normal saline eye drops. Results revealed no difference or advantage of topical anesthetic agents over normal saline. However, this study was not a cross-over study and did not apply validated pain score measures.[13] Later on, Marsh et al. carried out a cross-over trial, where all infants had been swaddled and held during examination. Premature infant pain profile (PIPP) scores were significantly higher in saline compared to proparacaine In addition, even though topical anesthetics decreased painful response in some infants, further comfort measures needed to be taken in cases where it was not as effective.[14] Moreover, Cogen et al. studied premature infants in a RCT where proparacaine 0.5% drops or artificial tear solution were administered, but comfort methods were abstained. The authors found that only 27% of proparacaine group experienced high PIPP scores, compared to 65% in placebo group. Thus, topical anesthetics could significantly decrease infants' pain.[15] Reviewed articles for topical anesthesia during ROP screening are summarized in [Table 1].[12],[13],[14],[15],[16],[17],[18]
Table 1: Topical anesthesia during retinopathy of prematurity screening

Click here to view


Other pharmacological agents

Providing safe and effective pain control measures is fundamental in every procedure including ophthalmology examination of newborns.[19] Morphine – an opioid – is an example of a drug commonly used for moderate-to-severe acute pain control. Nevertheless, the risk of developing respiratory depression, apnea, hypotension, and urinary retention with opioid use is higher in preterm neonates.[20] Hence, Hartley et al. conducted an RCT to establish the safety of oral morphine in reducing nonventilated infants' pain undergoing painful procedures. Subjects were allocated to get 100 μg/kg of oral morphine or placebo, swaddling was done before eye examination and proxymetacaine 0.5% was instilled preceding speculum insertion. No significant difference in pain score was noticed between morphine and placebo. Furthermore, 53% of infants who received morphine developed new-onset apnea or an increase in the number of apneic episodes highlighting the disadvantages of morphine in these settings and, thus, justifying the trial cessation.[19]

On the other hand, fentanyl has a better respiratory safety profile, favorable hemodynamics, shorter duration, and rapid onset compared to morphine. Sindhur et al. conducted the first trial aimed to investigate the efficacy of 50 mcg/ml intranasal fentanyl as an adjunct for pain management during ROP examination, all subjects received 24% oral sucrose and topical proparacaine 0.5%. Results illustrated that PIPP score, heart rate, and crying time during retinal examination were lower in fentanyl group compared to placebo. This study found that fentanyl significantly reduced pain scores but could not eliminate pain completely and cautioned against possible fentanyl side effects.[21]

In pediatric practice, paracetamol is used regularly due to its good safety profile and absence of significant side effects. Kabataş et al. randomly assigned infants to either 15 mg/kg oral paracetamol or sterile water of the same volume, in addition to propracaine 0.5% eye drops before clinical examinations. During eye examination and speculum insertion, PIPP score was significantly lower in the intervention group, and no side effects were observed.[22]

Inhalational anesthetic agents have been widely used in day surgery due to their favorable safety profile and efficacy in inducing and maintaining anesthesia. Two papers studied sevoflurane and nitrous oxide (N2O) in reducing infant discomfort during ophthalmology examination. Yu et al. concluded that 6% of inhaled sevoflurane can be safely used in preventing infant movements during eye examination, and no side effects were reported during or after the procedure.[23] Mandel et al. studied inhaled equimolar mixture of N2O (EMONO) and oxygen (EMONO) via nasal cannula for pain relief. All infants received standard care measures, including: swaddling, 24% of oral sucrose, and one drop of proparacaine HCl 0.5%. EMONO did not provide extra beneficial pain relief over the currently used measures which was argued to be due to mode of delivery, nasal cannula versus facemask, and the inherent minimal anesthetic and analgesic properties of EMONO. Nevertheless, EMONO was tolerated without any side effects.[24] [Table 2] summarizes studies related to pharmacological agents used in ROP screening.[19],[21],[22],[23],[24]
Table 2: Other pharmacological agents used during retinopathy of prematurity screening

Click here to view


Nonpharmacological measures

Oral glucose

Despite the use of topical anesthetics prior to infant eye examination, ROP screening remains painful to infants. Orally administered dextrose has a role in relieving newborns' pain, mechanism of action is still unknown, but it is thought to be related to indirect endogenous opioid or dopamine release. Oral glucose is a safe and widely available solution used in infants undergoing stressful procedures.[25],[26] There are four RCTs which employed oral dextrose in premature neonates undergoing ROP examination. Two of them found no significant effect for oral glucose over sterile water or expressed breast milk.[25],[27] Another study found that 1 ml of 25% oral glucose was significantly effective in pain prevention.[28] Similarly, Sagheb et al. found that 25% dextrose and topical anesthesia reduced the PIPP score significantly when compared to water and nothing by mouth.[26] These studies stressed on the need of further studies to properly evaluate the efficacy and safety of higher doses of glucose or dextrose as a pain prevention measure during ROP screening.

Oral sucrose

It is hypothesized that sucrose activates lingual sweet taste receptors leading to endogenous opioid release, and combination with nonnutritive sucking (NNS) can activate nonopioid mechanism, thus reducing pain and stress.[29] RCT results varied with studies concluding no analgesic effect at all as compared to sterile water with a possibility that only a pacifier may decrease pain/stress associated with ROP, to other studies finding a clear benefit of oral sucrose in reducing immediate procedural pain response compared to placebo. Other studies even suggested the need to provide both oral sucrose and a pacifier to decrease behavioral and physiological pain responses.[30],[31],[32],[33],[34],[35] Seifi et al. compared oral sucrose to paracetamol and found lower PIPP scores at the beginning of eye examination.[36] They found that better PIPP scores at the end of eye examination can be achieved by repeating the dose or increasing the volume of sucrose.[36]

Breast milk

Breast milk has been found to be a good analgesic agent in painful procedures, and might have more advantages over other analgesics. It is a natural, safe, feasible, and cost-effective agent, and contains high concentration of tryptophan, an essential amino acid with pain-relieving properties.[25] Rosali et al. assessed whether expressed breast milk is an effective pain control measure during eye examination. Findings revealed that expressed breast milk has the ability to reduce infant pain, as assessed by PIPP scale, during the procedure and for 5 min afterward.[37] Ribeiro et al. performed a quasi-experimental study, the intervention group was given 2 ml of breast milk, whereas the control received 25% of oral sucrose (0.5 ml/kg), all infants received proxymetacaine eye drops before the examination. Crying time, salivary cortisol, and heart rate did not yield statistical significance between the two groups; hence, breast milk is as effective as sucrose in relieving acute pain during ROP screening.[38]

Articles assessing nonpharmacological measures during ROP screening are shown in [Table 3].[25],[26],[27],[28],[30],[31],[32],[33],[34],[35],[36],[37],[38],[39],[40],[41]
Table 3: Nonpharmacological measures used during retinopathy of prematurity screening

Click here to view


Comfort measures

To date, numerous analgesic methods have been implemented to control infant pain during ROP examination including nonpharmacological techniques such as swaddling and nonnutritive suckling. Such measures have a clear analgesic effect by distracting newborns and preventing pain from transmitting to the cerebral cortex.[42]

A trial to determine if comfort care measures would ameliorate infant pain during ROP examination has been conducted. All groups were instilled with 0.5% proparacaine, the intervention group were swaddled, given 24% sucrose pacification, and were held by a nurse, whereas the control group did not receive any relieving measures. The authors could not recommend the routine use of the aforementioned techniques as effective in reducing infant pain; instead, they advised ophthalmologists to perform ROP examination as quick and safe as possible and to use topical anesthetics prior to eye examination.[43]

Newborn Individualized Developmental Care and Assessment Program (NIDCAP) in reducing infant pain during retinal examination was investigated by Kleberg.[44] NIDCAP care consisted of dimmed lighting, reduced sound and activity levels, and standard bed support; this intervention did not abolish infant pain but helped subjects to recover faster after examination as indicated by a faster decrease in cortisol level.[44] Chuang et al. compared the modified developmental care bundle versus standard care in decreasing premature pain and stress during eye examination. The modified developmental care bundle included environmental modifications, positioning and containment, oxygen supplementation, interaction and approach, and cue-based individual care, applied before, during, and after the ROP examination. They stated that recovery time was significantly shorter in the intervention group; moreover, bundle of comfort measures significantly reduced pain and stress during ophthalmic examination and 1 h afterward.[45]

Multisensory stimulation program (visual, taste, tactile, and smell stimulations) had been studied on premature infants undergoing retinal examination by Zeraati who concluded that multisensory stimulation program is a safe, simple, and effective method in reducing infant stress and pain, and suggested future studies comparing this program with other nonpharmacological methods in reducing pain associated with eye examination.[46]

Infant's position and body posture play an important role in increasing the sense of security which, in turn, reduces energy expenditure.[47] Three articles assessed the concept of infant's settings: Slevin et al. evaluated the role of nesting, Padhi et al. examined the effect of reverse kangaroo mother care (R-KMC), and Metreş and Yıldız determined the result of ROP position.[47],[48],[49] Nesting appears to be a beneficial method in reducing infant discomfort and crying time.[47] The pilot study of R-KMC (baby is rotated 180° and lies supine on the mother's chest) revealed that most of the infants were comfortable or had just a transient mild-to-moderate pain during ROP examination.[48] Furthermore, a randomized trial was conducted to study the efficacy of ROP position (he infant will be held in an ideal position, the nurse will support the infant's lower extremities in a cocoon shape while keeping the head immobilized). Findings showed lower PIPP scores at the beginning, at the end of screening, and after the examination. In addition, lower heart rate and shorter crying time were noticed compared to the control group who received a pacifier only.[49] A meta-analysis was conducted by Disher et al. reported that topical anesthetics combined with multisensory pain interventions (e.g.; sweet taste in addition to NNS, or sweet taste in addition to familiar odor) is more likely to be the optimal method in lowering premature infants pain undergoing eye examination.[50] [Table 4] summarizes studies assessing comfort measures during ROP screening.[42],[43],[44],[45],[46],[47],[49],[50],[51]
Table 4: Comfort measures during retinopathy of prematurity screening

Click here to view


Retinopathy of prematurity treatment

Topical/local anesthesia

Laser treatment under topical/local anesthesia for ROP has been the preferred method in developing countries due to the absence of specialized pediatric anesthetists and inaccessibility to GA.[52],[53] However, topical anesthesia is insufficient for laser treatment and may raise the risk of life-threatening events including cardiorespiratory instability.[54] Sub-Tenon local anesthesia appears to suppress the oculocardiac reflex which minimizes cardiorespiratory instability till few hours after treatment. Moreover, it enhances pupillary dilatation as pupils are resistant to pharmacological dilatation due to iris vasculature engorgement.[54]

Parulekar et al. and Novitskaya et al. tested the efficacy of sub-Tenon anesthesia and oral/rectal sedation for laser treatment of ROP. Findings suggest that sub-Tenon anesthesia with oral/rectal sedation can sufficiently control pain during ROP laser treatment, and it is believed to be an alternative to GA with lesser morbidity.[54],[55] Peribulbar block, using lidocaine or bupivacaine or combination of both, in conjunction with GA for infants undergoing vitreoretinal surgery for ROP was studied by Sinha and Maitra All subjects were hemodynamically stable intraoperatively, none had apnea or desaturation, no one required postoperative neonatal intensive care unit (NICU) admission, and none required analgesia postoperatively. They concluded that peribulbar block is safe, and its sparing effects are speculated to be the reason for the low incidence of postoperative complications.[56]

A trial by Kataria et al. tested oral dextrose (25%) plus topical anesthesia to reduce pain associated with laser treatment for ROP. PIPP scores during laser treatment were high irrespective of oral dextrose or topical anesthesia use. It also did not seem to provide any additional pain relief.[57]

Intravitreal injections have been used for infants with aggressive ROP, it could be carried out under topical anesthesia as it is a quick procedure. Castellanos et al. performed a noncomparative trial to assess pain response during intravitreal bevacizumab injections for ROP under topical anesthesia. Tetracaine 0.5 g/ml has been used and was found to be effective, as the majority of infants experienced mild discomfort only.[58] Studies evaluating topical/local anesthesia during ROP treatment are shown in [Table 5].[54],[55],[56],[57],[58]
Table 5: Topical/local anesthesia during retinopathy of prematurity treatment

Click here to view


Sedoanalgesia

Many institutes prefer the use of sedation/analgesia at the bedside in the NICU settings rather than GA to improve patient stability and avoid intubation and transportation to the operation room, thus reducing risk of hypothermia.[9],[59],[60],[61],[62] Opioids such as fentanyl, morphine, and remifentanil have been used and tested for this purpose. Kirwan et al. concluded that morphine is a safe and effective sedoanalgesia in laser treatment for ROP, and can be used as an alternative to GA with a good hemodynamic record.[60]

Örge et al. revealed that fentanyl is safer when compared to morphine in infants undergoing laser photocoagulation.[63] Dannelley et al. found that fentanyl and midazolam continuous infusions achieved successful results when applied in laser treatment procedures.[64] Opioids (fentanyl and morphine) and neuromuscular agents (vecuronium and rocuronium) in conjunction with midazolam were tested for the first time by Miller et al. for infants receiving intravitreal bevacizumab injections. Majority of infants had successful procedures, defined as no procedural interruption nor cardiopulmonary adverse events.[65]

Ketamine is a short-acting agent with a prolonged analgesic effect, protects laryngeal and pharyngeal reflexes, and has a bronchodilator effect; hence, it is the preferred drug of choice in pediatric anesthesia.[66],[67] Lyon et al. supported the use of ketamine sedation for infants undergoing ophthalmic laser procedure; despite the few intra- and postoperative complications and excessive infant movements, the majority of infants had successful and uneventful procedures.[68] Comparably, Saylan et al. reported that most of their subjects (86.2%) had successfully completed the laser treatment for ROP and achieved spontaneous ventilation under ketamine and midazolam protocol.[66] In both aforementioned studies, atropine was used to minimize salivation and to suppress the oculocardiac reflex produced by ketamine.

Jiang et al. compared three techniques of anesthesia (topical anesthesia, IV Fentanyl sedation, and GA using Halothane), results revealed that both GA and sedoanalgesia are well tolerated and no life-threatening events were reported compared to topical anesthetics. However, in terms of financial and time costs, fentanyl analgesia appears to be the most practical.[69] In addition, But et al. concluded that sevoflurane–N2O and midazolam–remifentanil anesthesia techniques had similar hemodynamics, intraoperative complications, and extubation times, thus both can be safely used for premature infants during laser treatment for ROP.[70] [Table 6] illustrates reviewed sedoanalgesia articles during ROP treatment.[60],[62],[63],[64],[65],[66],[68],[69],[70],[71],[72],[73],[74],[75]
Table 6: Sedoanalgesia during retinopathy of prematurity treatment

Click here to view


General anesthesia

Types and forms of anesthesia during ROP treatment vary widely between different eye institutes; therefore, several observational studies have been conducted to evaluate the most commonly employed form of anesthesia for ROP treatments. In 1995, Schulenburg screened all neonatal units in the UK, and concluded that most of the units were using cryotherapy for ROP treatment and GA was employed in the majority of units (57%).[8] Moreover, Chen et al. surveyed ophthalmologists in the UK and found that majority (50%) of them preferred GA for laser treatment followed by intravenous sedation with topical anesthesia (37%). The remaining (3% each) used oral sedation combined with topical anesthesia, rectal chloral hydrate and paracetamol combined with topical anesthesia, intravenous ketamine combined with topical anesthesia, or sub-Tenon's local anesthesia. This variation in practice might be related to different beliefs, experiences, safety concerns, and resource limitations of individual physicians.[9] In a Turkish survey, 72.7% of the ophthalmologists preferred GA, while 20.5% used intravenous sedation combined with topical anesthesia.[16]

Sato et al. concluded that air, oxygen, and sevoflurane inhalation should be adopted as the best anesthetic protocol compared to local anesthesia, intravenous pentazocine, and intravenous fentanyl.[76] Sevoflurane is a good agent for day surgery and widely used in infants, as it enables rapid induction and recovery and does not cause respiratory irritation.[77],[78] In two recent retrospective studies, results revealed that GA with sevoflurane can be safely used in infants undergoing argon/diode laser photocoagulation for ROP. However, it carries moderate rates of intraoperative hypotension and postextubation apnea.[79],[80] Likewise, for aggressive ROP requiring vitrectomy, studies have shown that half of the patients were successfully extubated in the operating room, no postoperative complications were observed, and that early vitrectomy is effective despite the perioperative risks.[81]

Evaluation of the perioperative and postoperative courses in neonates undergoing vitreoretinal surgery for ROP under GA using sevoflurane with atracurium and fentanyl was performed by Sinha et al. and concluded that as low as 5.36% of studied subjects had postoperative apnea. This is thought to be due to reduced intraoperative opioid doses with the use of paracetamol and topical anesthetics.[82] A summary of reviewed GA studies during ROP treatment is shown in [Table 7].[8],[9],[16],[59],[76],[79],[80],[81],[82],[83],[84],[85],[86],[87],[88]
Table 7: General anesthesia during retinopathy of prematurity treatments

Click here to view



  Conclusion Top


Achieving a universal standard of care for pain control measures during ROP screening is still controversial and has yet to be established. However, implementing topical anesthesia, NNS, swaddling, and sweet solution during ROP examination was observed as a common effective practice in many institutes. Laser treatments using GA and sedoanalgesia are the most preferred protocols. Numerous neonatal units lack the availability of specialized anesthesiologists, thus sedoanalgesia was noted to be the second most common technique. Further studies are required to determine the best standard of care and the most appropriate guideline for the type of anesthesia/analgesia during different ROP treatment interventions.

Financial support and sponsorship

Nil.

Conflicts of interest

There are no conflicts of interest.



 
  References Top

1.
Hashemieh M, Nassiri N. Retinopathy of Prematurity: A Brief Review of Literature. J Ophthalmol Opto Sci 2017;1:29-35.  Back to cited text no. 1
    
2.
Gilbert C, Blencowe H. Retinopathy of prematurity: It is time to take action. Community Eye Health 2017;30:45-8.  Back to cited text no. 2
    
3.
Gilbert C. Retinopathy of prematurity: A global perspective of the epidemics, population of babies at risk and implications for control. Early Hum Dev 2008;84:77-82.  Back to cited text no. 3
    
4.
Al-Qahtani B, Al-Otaibi M, Alabdulajabbar K, Selayem NB, Alshehri W, Omair A, et al. Retinopathy of prematurity incidence and risk factors in a tertiary hospital in Riyadh, Saudi Arabia. Middle East Afr J Ophthalmol 2019;26:235-9.  Back to cited text no. 4
[PUBMED]  [Full text]  
5.
Fierson WM. Screening examination of premature infants for retinopathy of prematurity. Pediatrics 2013;131:189-95.  Back to cited text no. 5
    
6.
Gregory GA, Steward DJ. Life-threatening perioperative apnea in the ex-”premie”. Anesthesiology 1983;59:495-8.  Back to cited text no. 6
    
7.
Tay-Uyboco JS, Kwiatkowski K, Cates DB, Kavanagh L, Rigatto H. Hypoxic airway constriction in infants of very low birth weight recovering from moderate to severe bronchopulmonary dysplasia. J Pediatr 1989;115:456-9.  Back to cited text no. 7
    
8.
Schulenburg WE, Bloom PA. Current problems in the management of ROP. Acta Ophthalmol Scand Suppl 1995;(214):14-6.  Back to cited text no. 8
    
9.
Chen SD, Sundaram V, Wilkinson A, Patel CK. Variation in anaesthesia for the laser treatment of retinopathy of prematurity – A survey of ophthalmologists in the UK. Eye (Lond) 2007;21:1033-6.  Back to cited text no. 9
    
10.
Mitchell AJ, Green A, Jeffs DA, Roberson PK. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care 2011;11:291-7.  Back to cited text no. 10
    
11.
Jefferies AL; Canadian Paediatric Society; Fetus and Newborn Committee. Retinopathy of prematurity: An update on screening and management. Paediatr Child Health 2016;21:101-8.  Back to cited text no. 11
    
12.
Ahmed M, Forcina B, Bonsall D. Quantifying and qualifying the use of topical anesthetics in retinopathy of prematurity examinations. J AAPOS 2016;20:177-8.  Back to cited text no. 12
    
13.
Saunders RA, Miller KW, Hunt HH. Topical anesthesia during infant eye examinations: Does it reduce stress? Ann Ophthalmol 1993;25:436-9.  Back to cited text no. 13
    
14.
Marsh VA, Young WO, Dunaway KK, Kissling GE, Carlos RQ, Jones SM, et al. Efficacy of topical anesthetics to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Ann Pharmacother 2005;39:829-33.  Back to cited text no. 14
    
15.
Cogen MS, Parker JS, Sleep TE, Elsas FJ, Metz TH, McGwin G. Masked trial of topical anesthesia for retinopathy of prematurity eye examinations. J AAPOS 2011;15:45-8.  Back to cited text no. 15
    
16.
Sekeroglu MA, Hekimoglu E, Sekeroglu HT, Arslan U. Retinopathy of prematurity: A nationwide survey to evaluate current practices and preferences of ophthalmologists. Eur J Ophthalmol 2013;23:546-52.  Back to cited text no. 16
    
17.
Mehta M, Mansfield T, VanderVeen DK. Effect of topical anesthesia and age on pain scores during retinopathy of prematurity screening. J Perinatol 2010;30:731-5.  Back to cited text no. 17
    
18.
Nesargi SV, Nithyanandam S, Rao S, Nimbalkar S, Bhat S. Topical anesthesia or oral dextrose for the relief of pain in screening for retinopathy of prematurity: A randomized controlled double-blinded trial. J Trop Pediatr 2015;61:20-4.  Back to cited text no. 18
    
19.
Hartley C, Moultrie F, Hoskin A, Green G, Monk V, Bell JL, et al. Analgesic efficacy and safety of morphine in the Procedural Pain in Premature Infants (Poppi) study: Randomised placebo-controlled trial. Lancet 2018;392:2595-605.  Back to cited text no. 19
    
20.
Anand KJ, Hall RW, Desai N, Shephard B, Bergqvist LL, Young TE, et al. Effects of morphine analgesia in ventilated preterm neonates: Primary outcomes from the NEOPAIN randomised trial. Lancet 2004;363:1673-82.  Back to cited text no. 20
    
21.
Sindhur M, Balasubramanian H, Srinivasan L, Kabra NS, Agashe P, Doshi A. Intranasal fentanyl for pain management during screening for retinopathy of prematurity in preterm infants: A randomized controlled trial. J Perinatol 2020;40:881-7.  Back to cited text no. 21
    
22.
Kabataş EU, Dursun A, Beken S, Dilli D, Zenciroğlu A, Okumuş N. Efficacy of single dose oral paracetamol in reducing pain during examination for retinopathy of prematurity: A blinded randomized controlled trial. Indian J Pediatr 2016;83:22-6.  Back to cited text no. 22
    
23.
Yu L, Sun H, Yao L, Feng Y, Yang B. Comparison of effective inspired concentration of sevoflurane in preterm infants with different postconceptual ages. Paediatr Anaesth 2011;21:148-52.  Back to cited text no. 23
    
24.
Mandel R, Ali N, Chen J, Galic IJ, Levesque L. Nitrous oxide analgesia during retinopathy screening: A randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2012;97:F83-7.  Back to cited text no. 24
    
25.
Nayak R, Nagaraj KN, Gururaj G. Prevention of pain during screening for retinopathy of prematurity: A randomized control trial comparing breast milk, 10% dextrose and sterile water. Indian J Pediatr 2020;87:353-8.  Back to cited text no. 25
    
26.
Sagheb S, Mosayebi Z, Karimi N, Nikseresht Z, Ani MM. Efficacy of 25% Glucose in Pain Alleviation During Retinopathy of Prematurity (ROP) Screening: A Randomized Controlled Trial. Acta Med Iran 2021;58:621-4.  Back to cited text no. 26
    
27.
Olsson E, Eriksson M. Oral glucose for pain relief during eye examinations for retinopathy of prematurity. J Clin Nurs 2011;20:1054-9.  Back to cited text no. 27
    
28.
Costa MC, Eckert GU, Fortes BG, Fortes Filho JB, Silveira RC, Procianoy RS. Oral glucose for pain relief during examination for retinopathy of prematurity: A masked randomized clinical trial. Clinics (Sao Paulo) 2013;68:199-204.  Back to cited text no. 28
    
29.
Gibbins S, Stevens B. Mechanisms of sucrose and non-nutritive sucking in procedural pain management in infants. Pain Res Manag 2001;6:21-8.  Back to cited text no. 29
    
30.
Boyle EM, Freer Y, Khan-Orakzai Z, Watkinson M, Wright E, Ainsworth JR, et al. Sucrose and non-nutritive sucking for the relief of pain in screening for retinopathy of prematurity: A randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2006;91:F166-8.  Back to cited text no. 30
    
31.
Gal P, Kissling GE, Young WO, Dunaway KK, Marsh VA, Jones SM, et al. Efficacy of sucrose to reduce pain in premature infants during eye examinations for retinopathy of prematurity. Ann Pharmacother 2005;39:1029-33.  Back to cited text no. 31
    
32.
Mitchell A, Stevens B, Mungan N, Johnson W, Lobert S, Boss B. Analgesic effects of oral sucrose and pacifier during eye examinations for retinopathy of prematurity. Pain Manag Nurs 2004;5:160-8.  Back to cited text no. 32
    
33.
Dilli D, Ilarslan NE, Kabataş EU, Zenciroǧlu A, Şimşek Y, Okumuş N. Oral sucrose and non-nutritive sucking goes some way to reducing pain during retinopathy of prematurity eye examinations. Acta Paediatr Int J Paediatr 2014;103:76-9.  Back to cited text no. 33
    
34.
O'Sullivan A, O'Connor M, Brosnahan D, McCreery K, Dempsey EM. Sweeten, soother and swaddle for retinopathy of prematurity screening: A randomised placebo controlled trial. Arch Dis Child Fetal Neonatal Ed 2010;95:F419-22.  Back to cited text no. 34
    
35.
Grabska J, Walden P, Lerer T, Kelly C, Hussain N, Donovan T, et al. Can oral sucrose reduce the pain and distress associated with screening for retinopathy of prematurity? J Perinatol 2005;25:33-5.  Back to cited text no. 35
    
36.
Seifi F, Peirovifar A, Mostafa Gharehbaghi M. Comparing the efficacy of oral sucrose and acetaminophen in pain relief for ophthalmologic screening of retinopathy of prematurity. Am J Med Sci Med 2013;1:24-7.  Back to cited text no. 36
    
37.
Rosali L, Nesargi S, Mathew S, Vasu U, Rao SP, Bhat S. Efficacy of expressed breast milk in reducing pain during ROP screening – A randomized controlled trial. J Trop Pediatr 2015;61:135-8.  Back to cited text no. 37
    
38.
Ribeiro LM, Castral TC, Montanholi LL, Daré MF, Silva AC, Antonini SR, et al. Human milk for neonatal pain relief during ophthalmoscopy. Rev Esc Enferm USP 2013;47:1039-45.  Back to cited text no. 38
    
39.
Şener Taplak A, Erdem E. A comparison of breast milk and sucrose in reducing neonatal pain during eye exam for retinopathy of prematurity. Breastfeed Med 2017;12:305-10.  Back to cited text no. 39
    
40.
Mirlashari J, Holsti L, Begjani J, Roohipoor R, Kasaeian A, Fakhr AS. Comparison of breast milk and sucrose in neonatal pain relief and coping with stress of ROP examination using ALPS-Neo. Iran J Neonatol 2021;12:46-55.  Back to cited text no. 40
    
41.
Wang DN, Lavery K, Dalgleish S, Howlett A, Hill VE, Dotchin SA. Reducing discomfort of eye drops prior to retinal examination in the neonatal intensive care unit. J Perinatol 2020;40:1857-62.  Back to cited text no. 41
    
42.
Sun Y, Zhang J, Chen X, Yang Y, Qiu J, Lu KY, et al. Effectiveness of gentle human touch for pain control during examination for retinopathy of pre-maturity: A randomized controlled trial. Front Pediatr 2020;8:608378.  Back to cited text no. 42
    
43.
Rush R, Rush S, Ighani F, Anderson B, Irwin M, Naqvi M. The effects of comfort care on the pain response in preterm infants undergoing screening for retinopathy of prematurity. Retina 2005;25:59-62.  Back to cited text no. 43
    
44.
Kleberg A, Warren I, Norman E, Mörelius E, Berg AC, Mat-Ali E, et al. Lower stress responses after Newborn Individualized Developmental Care and Assessment Program care during eye screening examinations for retinopathy of prematurity: A randomized study. Pediatrics 2008;121:e1267-78.  Back to cited text no. 44
    
45.
Chuang LJ, Wang SH, Ma MC, Lin CN, Chen CL, Huang MC. A modified developmental care bundle reduces pain and stress in preterm infants undergoing examinations for retinopathy of prematurity: A randomised controlled trial. J Clin Nurs 2019;28:545-59.  Back to cited text no. 45
    
46.
Zeraati H, Shahinfar J, Behnam Vashani H, Reyhani T. Effect of multisensory stimulation on pain of eye examination in preterm infants. Anesth Pain Med 2017;7:e42561.  Back to cited text no. 46
    
47.
Slevin M, Murphy JF, Daly L, O'Keefe M. Retinopathy of prematurity screening, stress related responses, the role of nesting. Br J Ophthalmol 1997;81:762-4.  Back to cited text no. 47
    
48.
Padhi TR, Sareen D, Pradhan L, Jalali S, Sutar S, Das T, et al. Evaluation of retinopathy of prematurity screening in reverse Kangaroo Mother Care: A pilot study. Eye (Lond) 2015;29:505-8.  Back to cited text no. 48
    
49.
Metreş Ö, Yıldız S. Pain management with ROP position in Turkish preterm infants during eye examinations: A randomized controlled trial. J Pediatr Nurs 2019;49:e81-9.  Back to cited text no. 49
    
50.
Disher T, Cameron C, Mitra S, Cathcart K, Campbell-Yeo M. Pain-relieving interventions for retinopathy of prematurity: A meta-analysis. Pediatrics 2018;142:e20180401.  Back to cited text no. 50
    
51.
Kristoffersen L, Støen R, Bergseng H, Follestad T, Theodorsson E, Vederhus B, et al. Skin-to-skin contact during eye examination did not reduce pain compared to standard care with parental support in preterm infants. Acta Paediatr 2019;108:1434-40.  Back to cited text no. 51
    
52.
Sekeroglu MA, Hekimoglu E, Sekeroglu HT. Topical anesthesia for laser treatment of retinopathy of prematurity. Paediatr Anaesth 2012;22:1224-5.  Back to cited text no. 52
    
53.
Jalali S, Azad R, Trehan HS, Dogra MR, Gopal L, Narendran V. Technical aspects of laser treatment for acute retinopathy of prematurity under topical anesthesia. Indian J Ophthalmol 2010;58:509-15.  Back to cited text no. 53
[PUBMED]  [Full text]  
54.
Parulekar MV, Chen SD, Patel CK. Sub-Tenon's local anaesthesia for the treatment of retinopathy of prematurity with diode laser. Eye 2008;22:375-9.  Back to cited text no. 54
    
55.
Novitskaya ES, Kostakis V, Broster SC, Allen LE. Pain score assessment in babies undergoing laser treatment for retinopathy of prematurity under sub-tenon anaesthesia. Eye (Lond) 2013;27:1405-10.  Back to cited text no. 55
    
56.
Sinha R, Maitra S. The effect of peribulbar block with general anesthesia for vitreoretinal surgery in premature and ex-premature infants with retinopathy of prematurity. A A Case Rep 2016;6:25-7.  Back to cited text no. 56
    
57.
Kataria M, Narang S, Chawla D, Sood S, Gupta PC. Oral dextrose for pain management during laser treatment of retinopathy of prematurity under topical anesthesia. Indian J Pediatr 2015;82:694-7.  Back to cited text no. 57
    
58.
Castellanos MA, Schwartz S, Leal R, Chan RV, Quiroz-Mercado H. Pain assessment in premature infants treated with intravitreal antiangiogenic therapy for retinopathy of prematurity under topical anesthesia. Graefes Arch Clin Exp Ophthalmol 2013;251:491-4.  Back to cited text no. 58
    
59.
Klein KS, Aucott S, Donohue P, Repka M. Anesthetic and airway management during laser treatment for retinopathy of prematurity: A survey of US ophthalmologists and neonatologists. J AAPOS 2013;17:221-2.  Back to cited text no. 59
    
60.
Kirwan C, O'Keefe M, Prendergast M, Twomey A, Murphy J. Morphine analgesia as an alternative to general anaesthesia during laser treatment of retinopathy of prematurity. Acta Ophthalmol Scand 2007;85:644-7.  Back to cited text no. 60
    
61.
Woodhead DD, Christensen RD. Sedation management during laser surgery for retinopathy of prematurity. J Perinatol 2007;27:529.  Back to cited text no. 61
    
62.
Piersigilli F, Di Pede A, Catena G, Lozzi S, Auriti C, Bersani I, et al. Propofol and fentanyl sedation for laser treatment of retinopathy of prematurity to avoid intubation. J Matern Fetal Neonatal Med 2019;32:517-21.  Back to cited text no. 62
    
63.
Örge FH, Lee TJ, Walsh M, Gordon K. Comparison of fentanyl and morphine in laser surgery for retinopathy of prematurity. J AAPOS 2013;17:135-9.  Back to cited text no. 63
    
64.
Dannelley JF, Johnson PN, Anderson MP, Oestreich K, Siatkowski RM, Miller JL. Assessment of outcomes with a sedation protocol during laser photocoagulation in preterm infants with retinopathy of prematurity. J Pediatr Pharmacol Ther 2018;23:410-6.  Back to cited text no. 64
    
65.
Miller JL, Johnson PN, Harkey K, Siatkowski RM. Sedation protocol during bevacizumab intravitreal injection in preterm infants with retinopathy of prematurity. J Pediatr Pharmacol Ther 2018;23:34-40.  Back to cited text no. 65
    
66.
Saylan S, Akdoğan A, Kader Ş, Tuğcugil E, Beşir A, Kola M, et al. Sedoanalgesia modality during laser photocoagulation for retinopathy of prematurity: Intraoperative complications and early postoperative follow-up. Ulus Travma Acil Cerrahi Derg 2020;26:754-9.  Back to cited text no. 66
    
67.
White PF, Way WL, Trevor AJ. Ketamine – Its pharmacology and therapeutic uses. Anesthesiology 1982;56:119-36.  Back to cited text no. 67
    
68.
Lyon F, Dabbs T, O'Meara M. Ketamine sedation during the treatment of retinopathy of prematurity. Eye 2008;22:684-6.  Back to cited text no. 68
    
69.
Jiang JB, Strauss R, Luo XQ, Nie C, Wang YL, Zhang JW, et al. Anaesthesia modalities during laser photocoagulation for retinopathy of prematurity: A retrospective, longitudinal study. BMJ Open 2017;7:e013344.  Back to cited text no. 69
    
70.
But A, Arikan M, Aslan B, Öztürk L, Tabuk M, Horasanli E. Comparison of anesthesia with sevofl urane-N2O and midazolam-remifentanil in low-birth-weight premature infants undergoing diode laser photocoagulation. Turk J Med Sci 2012;42:573-9.  Back to cited text no. 70
    
71.
Sammartino M, Bocci MG, Ferro G, Mercurio G, Papacci P, Conti G, et al. Efficacy and safety of continuous intravenous infusion of remifentanil in preterm infants undergoing laser therapy in retinopathy of prematurity: Clinical experience. Paediatr Anaesth 2003;13:596-602.  Back to cited text no. 71
    
72.
Demirel N, Bas AY, Kavurt S, Celik IH, Yucel H, Turkbay D, et al. Remifentanil analgesia during laser treatment for retinopathy of prematurity: A practical approach in neonatal intensive care unit. Am J Perinatol 2014;31:983-6.  Back to cited text no. 72
    
73.
Ulgey A, Güneş I, Bayram A, Aksu R, Biçer C, Uğur F, et al. Decreasing the need for mechanical ventilation after surgery for retinopathy of prematurity: sedoanalgesia vs. general anesthesia. Turk J Med Sci 2015;45:1292-9.  Back to cited text no. 73
    
74.
Novitskaya ES, Dahlmann-Noor AH, Adams GG, Allen LE. Retinopathy of prematurity treatment in the UK: trends in neonatal anaesthetic support and location of treatment from a national surveillance study. Eur J Pediatr 2020;179:1603-7.  Back to cited text no. 74
    
75.
Sethi A, Sankar MJ, Kulkarni S, Thukral A, Chandra P, Agarwal R. Low dose fentanyl infusion versus 24% oral sucrose for pain management during laser treatment for retinopathy of prematurity – An open label randomized clinical trial. Eur J Pediatr 2020;179:285-92.  Back to cited text no. 75
    
76.
Sato Y, Oshiro M, Takemoto K, Hosono H, Saito A, Kondo T, et al. Multicenter observational study comparing sedation/analgesia protocols for laser photocoagulation treatment of retinopathy of prematurity. J Perinatol 2015;35:965-9.  Back to cited text no. 76
    
77.
Goa KL, Noble S, Spencer CM. Sevoflurane in paediatric anaesthesia: A review. Paediatr Drugs 1999;1:127-53.  Back to cited text no. 77
    
78.
Eger EI 2nd. New inhaled anesthetics. Anesthesiology 1994;80:906-22.  Back to cited text no. 78
    
79.
Ugur B, Karsli G. Anesthetic management of argon laser photocoagulation in patients with premature retinopathy: Single center three-years experience of 178 cases. Ann Med Res 2021;28:5.  Back to cited text no. 79
    
80.
Kaur B, Carden SM, Wong J, Frawley G. Anesthesia management of laser photocoagulation for retinopathy of prematurity. A retrospective review of perioperative adverse events. Paediatr Anaesth 2020;30:1261-8.  Back to cited text no. 80
    
81.
Aoyama K, Kondou Y, Suzuki Y, Sakai H, Oshima M, Inada E. Anesthesia protocols for early vitrectomy in former preterm infants diagnosed with aggressive posterior retinopathy of prematurity. J Anesth 2010;24:633-8.  Back to cited text no. 81
    
82.
Sinha R, Talawar P, Ramachandran R, Azad R, Mohan VK. Perioperative management and post-operative course in preterm infants undergoing vitreo-retinal surgery for retinopathy of prematurity: A retrospective study. J Anaesthesiol Clin Pharmacol 2014;30:258-62.  Back to cited text no. 82
[PUBMED]  [Full text]  
83.
Tokgöz O, Sahin A, Tüfek A, Cınar Y, Güzel A, Ciftçi T, et al. Inhalation anesthesia with sevoflurane during intravitreal bevacizumab injection in infants with retinopathy of prematurity. Biomed Res Int 2013;2013:435387.  Back to cited text no. 83
    
84.
Gutierrez JA. Propofol for procedural anaesthesia during laser treatment of retinopathy of prematurity in the Neonatal Intensive Care Unit (NICU). J Neonatal Biol 2015;04:3-6.  Back to cited text no. 84
    
85.
Anand D, Etuwewe B, Clark D, Yoxall CW. Anaesthesia for treatment of retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 2007;92:F154-5.  Back to cited text no. 85
    
86.
Gunenc F, Kuvaki B, Iyilikci L, Gokmen N, Yaman A, Gokel E. Use of laryngeal mask airway in anesthesia for treatment of retinopathy of prematurity. Saudi Med J 2011;32:1127-32.  Back to cited text no. 86
    
87.
Zhang Q, Zhao H, Feng Y. Laryngeal mask airway with pressure support ventilation vs. endotracheal tube with pressure controlled ventilation in preterm infants undergoing ROP surgery: A propensity score matching analysis of perioperative complications. J Clin Anesth 2019;57:141-2.  Back to cited text no. 87
    
88.
Lönnqvist PA. Successful use of laryngeal mask airway in low-weight expremature infants with bronchopulmonary dysplasia undergoing cryotherapy for retinopathy of the premature. Anesthesiology 1995;83:422-4.  Back to cited text no. 88
    



 
 
    Tables

  [Table 1], [Table 2], [Table 3], [Table 4], [Table 5], [Table 6], [Table 7]



 

Top
 
 
  Search
 
Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
Access Statistics
Email Alert *
Add to My List *
* Registration required (free)

 
  In this article
Abstract
Introduction
Literature Search
Retinopathy of P...
Conclusion
References
Article Tables

 Article Access Statistics
    Viewed646    
    Printed12    
    Emailed0    
    PDF Downloaded69    
    Comments [Add]    

Recommend this journal


[TAG2]
[TAG3]
[TAG4]